At City of Hope, a powerful blend of precision oncology, spatial transcriptomics, and artificial intelligence is unlocking long-standing mysteries in colorectal cancer—particularly why it’s surging in young Hispanic and Latino individuals.
Using the 10x Genomics Visium platform, researchers mapped gene activity across tumor regions, revealing immune-cancer interactions and mutational hotspots previously undetectable. But the real disruptor? A proprietary Precision Medicine AI Agent (PM-AI) that integrates DNA, RNA, clinical, and social health data within hours—not weeks.
Could this be the beginning of a new era where AI delivers personalized care before patients even step into the clinic?